**Core Concept**
The blood-placental barrier is a selectively permeable barrier that restricts the passage of certain substances from the maternal bloodstream to the fetal circulation. This barrier is crucial for maintaining the homeostasis of the fetus and preventing the transfer of harmful substances. The passage of drugs across the blood-placental barrier is influenced by their molecular weight, lipid solubility, and degree of protein binding.

**Why the Correct Answer is Right**
The correct answer is a drug that has a high molecular weight and is highly bound to plasma proteins, which restricts its ability to cross the blood-placental barrier. This drug is also highly polar, making it less lipophilic and less likely to diffuse across the lipid-rich placental membrane. The specific mechanism of action and pharmacokinetic properties of the correct answer make it an ideal candidate for not crossing the blood-placental barrier.

**Why Each Wrong Option is Incorrect**
**Option A:** This drug is a low-molecular-weight, lipophilic compound that easily diffuses across the blood-placental barrier, making it available to the fetus.
**Option B:** This drug has a moderate molecular weight and moderate lipid solubility, allowing it to partially cross the blood-placental barrier and affect fetal development.
**Option D:** This drug has a similar molecular weight and lipid solubility profile to the correct answer but is less bound to plasma proteins, allowing it to cross the blood-placental barrier to some extent.

**Clinical Pearl / High-Yield Fact**
When prescribing medications to pregnant women, it is essential to consider the potential effects on the fetus and the ability of the drug to cross the blood-placental barrier. This knowledge can help minimize the risk of teratogenicity and ensure the safe use of medications during pregnancy.

**Correct Answer:** C. This drug does not cross the blood-placental barrier due to its high molecular weight, high protein binding, and low lipid solubility.